| Patents for C07D 221 - Heterocyclic compounds containing six-membered rings having one nitrogen atom as the only ring hetero atom, not provided for by groups (10,931) |
|---|
| 06/19/2001 | US6248753 Bicyclic compounds |
| 06/19/2001 | US6248750 9-hydroxyamino tetrahydroacridine and related compounds |
| 06/14/2001 | WO2001042219A2 Novel substituted phenanthridinones and methods of use thereof |
| 06/14/2001 | WO2001042207A2 Novel methods for the treatment and prevention of ileus |
| 06/14/2001 | CA2393567A1 Novel substituted phenanthridinones and methods of use thereof |
| 06/14/2001 | CA2393141A1 Novel methods for the treatment and prevention of ileus |
| 06/13/2001 | EP1105133A1 Tricyclic compounds |
| 06/13/2001 | CN1299361A Hypnotic beta-carboline derivatives, process for their prepn. and their use as medicinal products |
| 06/13/2001 | CN1299345A Method for stereochemically controlled production of isomerically pure highly substituted azacyclic compounds |
| 06/13/2001 | CN1067071C Carboline derivatives |
| 06/12/2001 | US6245775 Anticholesterol agents; cardiovascular disorders |
| 06/06/2001 | EP1104404A1 Substituted isoquinoline derivatives and their use as anticonvulsants |
| 06/06/2001 | EP0695752B1 anthraquinonic derivatives having an antitumor activity, and applications thereof |
| 06/06/2001 | CN1298394A Aryl fused azapolycyclic compounds |
| 06/05/2001 | US6242470 Rheumatic diseases; antiarthritic agents, antiallergens; irritable bowel syndrome; amidation |
| 06/05/2001 | US6242458 Tricyclic amide and urea compounds useful for inhibition of G-protein function and for treatment of proliferative diseases |
| 05/31/2001 | WO1999064041A9 Multibinding agents that modulate nmda receptors |
| 05/31/2001 | DE19957156A1 New amino and fluoro substituted 1,2,3,4,5,6-hexahydro-2,6-methano-3-benzazocine derivatives useful in treatment of e.g. arrythmias, spasms, ischaemia, pain and neurodegenerative disorders |
| 05/30/2001 | EP1103554A1 Derivatives of dihydrofuro-(3,4-b)-quinolein-1-ones, process of préparation and phamaceutical compositions containing them |
| 05/30/2001 | EP1102768A1 Substituted pyrazole derivatives condensed with six-membered heterocyclic rings |
| 05/30/2001 | EP1102597A1 Multivalent agonists, partial agonists, inverse agonists and antagonists of the 5ht 4 receptors |
| 05/30/2001 | EP0842153B1 Method of preparing norbenzomorphane as an intermediate in the preparation of pharmaceutically useful benzomorphane derivatives, in particular (-)-(1r,5s,2"r)-3'-hydroxy-2-(2-methoxypropyl)-5,9,9-trimethyl-6,7-benzomorphane |
| 05/29/2001 | US6239143 5-HT7 receptor antagonists |
| 05/23/2001 | EP1100802A1 OXAZOLO, THIAZOLO AND SELENAZOLO [4,5-c]-QUINOLIN-4-AMINES AND ANALOGS THEREOF |
| 05/23/2001 | EP1100794A1 COMPOUNDS SPECIFIC FOR THE HUMAN $g(a) 1d? ADRENERGIC RECEPTOR AND USES THEREOF |
| 05/23/2001 | EP1100781A1 High affinity ligands for nociceptin receptor orl-1 |
| 05/23/2001 | EP1100519A1 Multibinding agents that modulate nmda receptors |
| 05/23/2001 | EP0900218A4 Heterocyclic compounds |
| 05/22/2001 | US6235791 Using cis n-cyclohexyl-n-ethyl(3-(3-chloro-cyclohexylphenyl)allyl)amine |
| 05/22/2001 | US6235748 Oxo-substituted compounds, process of making, and compositions and methods for inhibiting parp activity |
| 05/17/2001 | WO2001034209A1 LIGANDS FOR α7 NICOTINIC ACETYLCHOLINE RECEPTORS BASED ON METHYLLYCACONITINE |
| 05/16/2001 | EP1098897A1 Compounds, compositions, and methods for stimulating neuronal growth and elongation |
| 05/16/2001 | EP1098882A1 A process for preparing benzocycloheptapyridin-11-ones |
| 05/16/2001 | EP1098870A2 Nitric esters and nitrate salts of specific drugs |
| 05/16/2001 | EP0839136B1 BENZO[g]QUINOLINE DERIVATIVES |
| 05/16/2001 | EP0798288B1 Triciclic compounds |
| 05/16/2001 | CN1295479A Beta 2-adrenergic receptor agonist |
| 05/15/2001 | US6232313 Pyridazino quinoline compounds |
| 05/08/2001 | US6229014 8-azaspiro(4.5)decane-1-one; antidepressants and treatment of psycholigical disorders, specifically memory loss |
| 05/08/2001 | US6228866 Administering nitric oxide synthase inhibitor to treat cancer and nervous system, brain, kidney, respiratory system, autoimmunes, skin and muscular disorders |
| 05/08/2001 | US6228865 Compounds useful for inhibition of farnesyl protein transferase |
| 05/08/2001 | US6228862 Increasing adipocyte differentiation |
| 05/08/2001 | US6228856 Compounds useful for inhibition of farnesyl protein transferase |
| 05/03/2001 | WO2001030333A2 Tissue factor antagonists and methods of use thereof |
| 05/03/2001 | CA2387857A1 Tissue factor antagonists and methods of use thereof |
| 05/02/2001 | EP1095016A1 Sulfur substituted sulfonylaminocarboxylic acid n-arylamides, their preparation, their use and pharmaceutical preparations comprising them |
| 05/02/2001 | EP1094826A1 Novel therapeutic agents that modulate alpha-1a adrenergic receptors |
| 05/02/2001 | EP1056974A4 Light polarizing materials, liquid suspensions and films thereof, and light valves incorporating same |
| 05/02/2001 | CN1293680A Method for producing aqueous polymer dispersions containing colorants |
| 05/02/2001 | CN1293669A Benzylpiperazingl-and benzylipeeridinyl ethanone derivatives, their preparation method and their use as dopamine D receptor antagonists |
| 05/01/2001 | CA2197178C Bicyclolactam compounds, use of the same and intermediate in the production of the same |
| 04/25/2001 | CN1292788A Bicyclic heteroaromatic compounds as protein tyrosine kinase inhibitors |
| 04/24/2001 | US6221606 Energy transfer dye comprising a donor dye which absorbs ight and emits exitation energy, an acceptor dye the absorbs the excitation energy and fluoresces in response, and a linker linking the two dyes, at least one is a dibenzorhodamine dye |
| 04/19/2001 | WO2001027099A2 Bicyclic compounds composition and method for stabilizing the same |
| 04/19/2001 | WO2001027086A1 Tetrahydroquinoline derivatives |
| 04/18/2001 | EP0968250B1 Soluble chromophores having improved solubilising groups |
| 04/18/2001 | CN1064684C Effective components of wild opium poppy and extracting process and product thereof |
| 04/17/2001 | US6218541 Method for extracting bisbenzylisoquinolines |
| 04/17/2001 | US6218431 Substituted biphenyls |
| 04/17/2001 | US6218404 Therapy and prophylaxis of neuronal loss associated with stroke, ischemia, cns trauma, hypoglycemia and surgery, neuro-degenerative diseases including alzheimer's disease, amyotrophic lateral sclerosis, huntington's disease |
| 04/17/2001 | US6218401 For therapy of pancreatic tumor cells, lung cancer cells, myeloid leukemia tumor cells, thyroid follicular tumor cells, myelodysplastic tumor cells, epidermal carcinoma tumor cells, bladder carcinoma tumor cells or prostate tumor cells |
| 04/17/2001 | CA2110670C Spiro piperidines and homologs which promote release of growth hormone |
| 04/17/2001 | CA2010963C Process for the preparation of lactam derivatives |
| 04/11/2001 | EP1089981A1 Compounds for inhibiting beta-amyloid peptide release and/or its synthesis. |
| 04/11/2001 | EP0662076B1 2-aminoalkyl-5-aminoalkylamino substituted isoquinoindazole-6-(2h)-ones with antitumour activity |
| 04/11/2001 | CN1064354C Trilcyclic benzazepine vasopressin antagnonists |
| 04/10/2001 | US6214839 Substituted 6-alkylphenanthridines |
| 04/10/2001 | US6214827 Tricyclic compounds useful for inhibition of G-protein function and for treatment of proliferative diseases |
| 04/05/2001 | DE19942700C1 Verfahren zur Herstellung cyclischer N-Hydroxydicarboximide A process for producing cyclic N-hydroxydicarboximides |
| 04/04/2001 | EP1087953A1 Nitrate salts of antihypertensive medicines |
| 04/04/2001 | EP0588796B1 Sampangine derivatives useful as antifungal and antimycobacterial agents |
| 04/04/2001 | CN1290251A N-acyl cyclic amine derivatives |
| 04/04/2001 | CN1290249A Aminoguanidine hydrazone derivatives, process for producing the same and drugs thereof |
| 03/28/2001 | EP1086066A1 Muscarinic receptor antagonists |
| 03/28/2001 | EP1085894A1 Beta 3-adrenergic receptor agonists |
| 03/28/2001 | EP1085889A2 Novel therapeutic agents that modulate endothelin receptors |
| 03/28/2001 | EP1085887A2 Novel angiotensin receptor modulators and their uses |
| 03/28/2001 | EP1085870A2 Multivalent agonists, partial agonists and antagonists of the gaba receptors |
| 03/28/2001 | EP1085868A1 H1-histamine receptor antagonists |
| 03/28/2001 | EP1085847A2 Novel therapeutic agents that modulate estrogen receptors |
| 03/27/2001 | US6207680 Heteroarylpiperidines and their use as antipsychotics and analgesics |
| 03/27/2001 | US6207677 Adminisering sigma receptor binding piperidine derivative for treating anxiety, epilepsy, convulsion, movement disorder, amnesia |
| 03/22/2001 | WO2000069862A3 Hemisynthetic method and intermediates thereof |
| 03/22/2001 | WO1999063936A8 Novel therapeutic agents that modulate endothelin receptors |
| 03/21/2001 | EP1085013A1 Process for the preparation of cyclic N-hydroxy-dicarboximides |
| 03/21/2001 | EP1083921A1 Novel leukotriene receptor antagonists and their uses |
| 03/21/2001 | EP1083917A1 Novel analgesic agents |
| 03/21/2001 | EP1083893A1 Multivalent agonists, partial agonists, inverse agonists and antagonists of the d 1? receptors |
| 03/21/2001 | EP1083888A1 MULTIBINDING AGENTS THAT MODULATE PPARgamma AND RXR RECEPTORS |
| 03/15/2001 | WO2001017972A2 Novel herbicides |
| 03/15/2001 | WO2001017356A1 Antimicrobial polymer |
| 03/15/2001 | WO2000074678A8 Analgesics |
| 03/14/2001 | EP1082306A1 Conformationally constrained amino acid compounds having affinity for the alpha2delta subunit of a calcium channel |
| 03/14/2001 | EP1082289A1 Methods for identifying novel multimeric agents that modulate receptors |
| 03/13/2001 | US6200983 For treating erectile dysfunction in psychogenic male patients; time-release agents |
| 03/08/2001 | WO2001016109A1 Thermochromic rylene dyes |
| 03/08/2001 | WO2001015656A2 Tricyclic compounds and their uses as antiarrhythmic antifibrillatory and defibrillatory agents |
| 03/08/2001 | WO1999063930A8 Novel angiotensin receptor modulators and their uses |
| 03/07/2001 | EP1081138A1 1,2-disubstituted 1,4-dihydro-4-oxoquinoline compounds |
| 03/07/2001 | EP1080092A2 Bicyclic pyrimidines and bicyclic 3,4-dihydropyrimidines as inhibitors of cellular proliferation |